Gelteq Ltd (NASDAQ: GELS)

$0.73 0.00 (-0.11%)
As of Apr 23, 2026 02:30 PM
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic CIK: 0001920092
Market Cap 4.51 Mn
P/E -1.65
P/S 42.52
Div. Yield 0.00
Total Debt (Qtr) 2.70 Mn
Add ratio to table...

About

Gelteq Ltd operates in the specialty chemicals industry, focusing on the development, manufacture, and distribution of gel-based products. The company specializes in creating innovative gel solutions for various applications, including personal care, industrial, and healthcare sectors. Gelteq Ltd's expertise lies in formulating gels that cater to specific market needs, leveraging advanced technology and research to maintain a competitive edge. The company generates revenue through the sale of its proprietary gel products, which are marketed under...

Read more

Categories of related parties [axis] Breakdown of Revenue (2025)

Geographical Breakdown of Revenue (2025)

Peer comparison

Companies in the Drug Manufacturers - Specialty & Generic
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 ZTS Zoetis Inc. 52.41 Bn 19.60 5.54 9.04 Bn
2 TEVA Teva Pharmaceutical Industries Ltd 35.83 Bn 25.23 2.08 16.81 Bn
3 UTHR UNITED THERAPEUTICS Corp 25.40 Bn 19.03 7.98 -
4 NBIX Neurocrine Biosciences Inc 12.96 Bn 27.02 4.53 -
5 HCM HUTCHMED (China) Ltd 12.76 Bn 28.06 23.27 0.09 Bn
6 ELAN Elanco Animal Health Inc 11.22 Bn -48.11 2.38 4.02 Bn
7 ALKS Alkermes plc. 5.52 Bn 22.80 3.74 -
8 LNTH Lantheus Holdings, Inc. 5.51 Bn 23.64 3.57 0.57 Bn